1. Home
  2. KZIA vs KDLY Comparison

KZIA vs KDLY Comparison

Compare KZIA & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • KDLY
  • Stock Information
  • Founded
  • KZIA 1994
  • KDLY 2019
  • Country
  • KZIA Australia
  • KDLY United States
  • Employees
  • KZIA N/A
  • KDLY N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • KDLY
  • Sector
  • KZIA Health Care
  • KDLY
  • Exchange
  • KZIA Nasdaq
  • KDLY NYSE
  • Market Cap
  • KZIA 7.8M
  • KDLY 7.8M
  • IPO Year
  • KZIA 1999
  • KDLY 2024
  • Fundamental
  • Price
  • KZIA $1.29
  • KDLY $1.24
  • Analyst Decision
  • KZIA Strong Buy
  • KDLY
  • Analyst Count
  • KZIA 2
  • KDLY 0
  • Target Price
  • KZIA $11.50
  • KDLY N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • KDLY 55.8K
  • Earning Date
  • KZIA 03-26-2025
  • KDLY 02-18-2025
  • Dividend Yield
  • KZIA N/A
  • KDLY N/A
  • EPS Growth
  • KZIA N/A
  • KDLY N/A
  • EPS
  • KZIA N/A
  • KDLY N/A
  • Revenue
  • KZIA $1,655,324.00
  • KDLY $2,875,400.00
  • Revenue This Year
  • KZIA $806.89
  • KDLY N/A
  • Revenue Next Year
  • KZIA N/A
  • KDLY N/A
  • P/E Ratio
  • KZIA N/A
  • KDLY N/A
  • Revenue Growth
  • KZIA 248000.00
  • KDLY N/A
  • 52 Week Low
  • KZIA $1.25
  • KDLY $0.65
  • 52 Week High
  • KZIA $15.80
  • KDLY $4.20
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 39.50
  • KDLY N/A
  • Support Level
  • KZIA $1.31
  • KDLY N/A
  • Resistance Level
  • KZIA $2.64
  • KDLY N/A
  • Average True Range (ATR)
  • KZIA 0.24
  • KDLY 0.00
  • MACD
  • KZIA 0.09
  • KDLY 0.00
  • Stochastic Oscillator
  • KZIA 14.29
  • KDLY 0.00

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: